KP Tissue Inc's stock has seen a positive uptick, closing at CA$13.08, marking a 1.47% gain in the last trading session.
In a market that often swings with uncertainty, KP Tissue Inc (KPT.TO) has managed to stand out with a notable gain of 1.47% in the last trading session. This rise brings its market cap to approximately CA$131 million, suggesting a resilient performance amidst broader market fluctuations.
Advertisement
KP Tissue Inc
KPT.TO
KPT.TO
KP Tissue Inc
WealthAwesomeMarket cap
$129.36M
P/E
14.3x
Div. yield
5.56%
Div. / share
$0.72
52W high
$13.61
52W low
$8.68
1W change
-0.93%
Beta
0.40
Analyst Price Targets
Based on analyst covering KPT
Wall Street analysts forecast KPT stock price to rise 0.6% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$12.88
+0.6% Upside
Current Price
C$12.80
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on KPT's historical volatility
30-Day Vol
15.6%
Annualized
90-Day Vol
16.1%
Annualized
Trend (90d)
+48.6%
Annualized drift
90d Mean
C$15.23
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$13.56 | C$12.85 – C$14.31 |
| 60 trading days | C$14.37 | C$13.32 – C$15.51 |
| 90 trading days | C$15.23 | C$13.87 – C$16.72 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: KP Tissue's recent performance may indicate investor confidence, particularly as the company gears up for its upcoming financial disclosures.
KP Tissue Inc closes at CA$13.08, up 1.47%
With a P/E ratio of 14.32, KP Tissue is positioned attractively compared to industry peers, potentially appealing to value-focused investors.
Bull case
The stock's upward movement could reflect positive sentiment as investors anticipate KP Tissue's upcoming financial results. Many expect these results to show strong profitability and operational efficiency, which could further boost confidence in the company.
Bear case
Despite the recent gain, investors should stay cautious. The lack of recent news might make the stock vulnerable to market corrections or profit-taking by investors. Keeping an eye on market trends is essential to navigate potential risks.
Current Market Performance
Advertisement
KP Tissue Inc's stock rose by 1.47% in the latest trading session, closing at CA$13.08. This increase is significant for investors looking for stability in a fluctuating market. With a market cap of CA$131 million, the company is relatively small but has shown resilience in its operations.
Future Outlook
Looking ahead, KP Tissue is expected to release its Q1 2026 financial results soon. Investors are keenly awaiting these figures, which may provide insights into the company's profitability and operational strategies. As noted in previous reports, strong earnings could further bolster investor confidence.
Valuation Metrics
With a P/E ratio of 14.32, KP Tissue's valuation appears competitive within its sector. This metric suggests that the stock may be undervalued compared to its peers, making it an attractive option for value investors. However, potential investors should weigh this against the company's profit margin, which currently stands at 0%.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
